Meyer Thomas 13D and 13G filings for Altamira Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-13 08:00 am Purchase |
2022-09-09 | 13D | Altamira Therapeutics Ltd. CYTO |
Meyer Thomas | 4,193 8.000% |
1,284 (+44.13%) |
Filing |
| 2022-05-13 08:32 am Purchase |
2022-05-12 | 13D | Altamira Therapeutics Ltd. CYTO |
Meyer Thomas | 2,909 7.400% |
2,909 (New Position) |
Filing |